Objective: To assess whether first year weight loss, age, and socioeconomic background correlate with the success rate of continuous long-term behavioral obesity treatment. Methods: In a 3-year longitudinal study, obese children (n = 684) were divided into three groups based on age at the start of treatment, age 6–9 years, 10–13 years, and 14–16 years. Results: The mean BMI standard deviation score (BMI-SDS) decline was age-dependent (p = 0.001), independently of adjustment for missing data: –1.8 BMI-SDS units in the youngest, –1.3 in the middle age group, and –0.5 in the oldest age group. SES and parental BMI status did not affect the results. 30% of the adolescents remained in treatment at year 3. There was only a weak correlation between BMI-SDS change after 1 and 3 years: r = 0.51 (p < 0.001). Among children with no BMI-SDS reduction during year 1 (n = 46), 40% had a clinically significantly reduced BMI-SDS after year 3. Conclusion: Behavioral treatment should be initiated at an early age to increase the chance for good results. Childhood obesity treatment should be continued for at least 3 years, regardless of the initial change in BMI-SDS.

Keywords:
Adolescent, Behavioral interventions, Childhood obesity, Lost to follow-up
1.
Luttikhuis HO, Baur L, Jansen H, Shrewsbury VA, O’Malley C, Stolk RP, Summerbell CD: Interventions for treating obesity in children. Cochrane Database Syst Rev 2009:CD001872.
2.
Epstein LH, Valoski A, Wing RR, McCurley J: 10-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol 1994;13:373–383.
3.
Reinehr T, Widhalm K, L’Allemand D, Wiegand S, Wabitsch M, Holl RW: Two-year follow-up in 21,784 overweight children and adolescents with lifestyle intervention. Obesity (Silver Spring) 2009;17:1196–1199.
4.
Reinehr T, Kleber M, Lass N, Toschke AM: Body mass index patterns over 5 y in obese children motivated to participate in a 1-y lifestyle intervention: Age as a predictor of long-term success. Am J Clin Nutr 2010;91:1165–1171.
5.
Danielzik S, Czerwinski-Mast M, Langnase K, Dilba B, Müller MJ: Parental overweight, socioeconomic status and high birth weight are the major determinants of overweight and obesity in 5–7 y-old children: Baseline data of the Kiel Obesity Prevention Study (KOPS). Int J Obes 2004;28:1494–1502.
6.
Pinelli L, Elerdini N, Faith MS, Agnello D, Ambruzzi A, De Simone M, Leggeri G, Livieri C, Monetti N, Peverelli P, Salvatoni A, Seminara S, Uasone R, Pietrobelli A: Childhood obesity: results of a multicenter study of obesity treatment in Italy. J Pediatr Endocrinol Metab 1999;12(suppl 3):795–799.
7.
Inelmen EM, Toffanello ED, Enzi G, Gasparini G, Miotto F, Sergi G, Busetto L: Predictors of drop-out in overweight and obese outpatients. Int J Obes 2005;29:122–128.
8.
Melin I, Reynisdottir S, Berglund L, Zamfir M, Karlstrom B: Conservative treatment of obesity in an academic obesity unit. Long-term outcome and drop-out. Eat Weight Disord 2006;11:22–30.
9.
Denzer C, Reithofer E, Wabitsch M, Widhalm K: The outcome of childhood obesity management depends highly upon patient compliance. Eur J Pediatr 2004;163:99–104.
10.
Barlow SE, Ohlemeyer CL: Parent reasons for nonreturn to a pediatric weight management program. Clin Pediatr 2006;45:355–360.
11.
Zeller M, Kirk S, Claytor R, Khoury P, Grieme J, Santangelo M, Daniels S: Predictors of attrition from a pediatric weight management program. J Pediatr 2004;144:466–470.
12.
Holm JC, Gamborg M, Bille DS, Gronbaek HN, Ward LC, Faerk J: Chronic care treatment of obese children and adolescents. Int J Pediatr Obes 2011;6:188–196.
13.
Danielsson P, Janson A, Norgren S, Marcus C: Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. J Clin Endocrinol Metab 2007;92:4101–4106.
14.
Norgren S, Danielsson P, Jurold R, Lotborn M, Marcus C: Orlistat treatment in obese prepubertal children: a pilot study. Acta Paediatrica 2003;92:666–670.
15.
Kamel A, Norgren S, Elimam A, Danielsson P, Marcus C: Effects of growth hormone treatment in obese prepubertal boys. J Clin Endocrinol Metab 2000;85:1412–1419.
16.
Baker JL, Farpour-Lambert NJ, Nowicka P, Pietrobelli A, Weiss R: Evaluation of the overweight/obese child – practical tips for the primary health care provider: recommendations from the Childhood Obesity Task Force of the European Association for the Study of Obesity. Obes Facts 2010;3:131–137.
17.
Barlow SE: Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120:S164–S192.
18.
Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D: Assessment of child and adolescent overweight and obesity. Pediatrics 2007;120:S193–S228.
19.
Spear BA, Barlow SE, Ervin C, Ludwig DS, Saelens BE, Schetzina KE, Taveras EM: Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics 2007;120:S254-S288.
20.
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: International survey. Br Med J 2000;320:1240–1243.
21.
Rolland Cachera MF, Sempe M, Guilloudbataille M, Patois E, Pequignot-Guggenbuhl F, Fautrad V: Adiposity indexes in children. Am J Clin Nutr 1982;36:178–184.
22.
WHO: Preventing and Managing the Global Epidemic of Obesity. Report of the World Health Organization Consultation of Obesity. Geneva, WHO, 1997
23.
Marcus C, Nyberg G, Nordenfelt A, Karpmyr M, Kowalski J, Ekelund U: A 4-year, cluster-randomized, controlled childhood obesity prevention study: Stopp. Int J Obes 2009;33:408–417.
24.
Reinehr T, Andler W: Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child 2004;89:419–422.
25.
Reinehr T, Kiess W, Kapellen T, Andler W: Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 2004;114:1569–1573.
26.
Reinehr T, Kleber M, Toschke AM: Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis 2009;207:174–180.
27.
Reinehr T, Temmesfeld M, Kersting M, De Sousa G, Toschke AM: Four-year follow-up of children and adolescents participating in an obesity intervention program. Int J Obesity 2007;31:1074–1077.
28.
Sabin MA, Ford A, Hunt L, Jamal R, Crowne EC, Shield JPH: Which factors are associated with a successful outcome in a weight management programme for obese children? J Eval Clin Pract 2007;13:364–368.
29.
Reinehr T, Hoffmeister U, Mann R, Goldapp C, Westenhofer J, Egmond-Froehlich A, Bullinger M, Ravens-Sieberer U, Holl RW: Medical care of overweight children under real-life conditions: The german bzga observation study. Int J Obes 2009;33:418–423.
30.
Lobstein T BLaUR: Obesity in children and young people: A crises in public health. Obes Rev 2004;5:4–85.
31.
Svensson V, Jacobsson JA, Fredriksson R, Danielsson P, Sobko T, Schioth HB, Marcus C: Associations between severity of obesity in childhood and adolescence, obesity onset and parental BMI: a longitudinal cohort study. Int J Obes 2011;35:46–52.
32.
Cameron JW: Self-esteem changes in children enrolled in weight management programs. Issues Compr Pediatr Nurs 1999;22:75–85.
33.
Jelalian E, Hart CN, Mehlenbeck RS, Lloyd-Richardson EE, Kaplan JD, Flynn-O’Brien KT, Wing RR: Predictors of attrition and weight loss in an adolescent weight control program. Obesity 2008;16:1318–1323.
34.
Timpka T, Angbratt M, Bolme P, Hermansson G, Hager A, Valter L: A high-precision protocol for identification of preschool children at risk for persisting obesity. PloS One 2007;2:e535.
35.
Gardner DSL, Hosking J, Metcalf BS, Jeffery AN, Voss LD, Wilkin TJ: Contribution of early weight gain to childhood overweight and metabolic health: a longitudinal study (earlybird 36). Pediatrics 2009;123:E67–E73.
36.
Nader PR, O’Brien M, Houts R, Bradley R, Belsky J, Crosnoe R, Friedman S, Mei ZG, Susman EJ: Identifying risk for obesity in early childhood. Pediatrics 2006;118:E594–E601.
37.
Karlberg J, Luo ZC, Albertsson-Wikland K: Body mass index reference values (mean and sd) for Swedish children. Acta Paediatrica 2001;90:1427–1434.
38.
Cole TJ: The lms method for constructing normalized growth standards. Eur J Clin Nutr 1990;44:45–60.
© 2012 S. Karger GmbH, Freiburg
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.